Kingsview Wealth Management, LLC Halozyme Therapeutics, Inc. Transaction History

Kingsview Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Dec 03, 2021	SELL	$38.47 - $46.42 $196,004 - $236,509	-5,095 Closed	0 $0
Q2 2021 Aug 17, 2021	SELL	$38.84 - $51.31 $180,606 - $238,591	-4,650 Reduced 47.72%	5,095 $236,000
Q1 2021 May 24, 2021	SELL	$39.51 - $51.45 $6,914 - $9,003	-175 Reduced 1.76%	9,745 $413,000
Q4 2020 Feb 16, 2021	BUY	$25.81 - $43.62 $256,035 - $432,710	9,920 New	9,920 $424,000

544

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.66B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kingsview Wealth Management, LLC with notifications on news.